Jul 2026
Targeting PD-1/PD-L1 and CTLA-4 Immune Checkpoints for Therapeutic Advancement in Hepatocellular Carcinoma.
The complex interplay between PD-1/PD-L1 and CTLA-4 pathways in HCC underscores the complexity of immune escape mechanisms, andTargeting these checkpoints has the potential to reshape HCC treatment, offering hope for more effective and durable outcomes.
K. Sharma, Hema Barti, Siddhant Jai Tyagi et al.
· Current Gene Therapy · 0 citations